UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
CORMEDIX INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware | 20-5894890 | ||
(State of Incorporation or Organization) | (I.R.S. Employer Identification no.) | ||
86 Summit Avenue, Suite 301, Summit, NJ | 07901-3647 | ||
(Address of Principal Executive Offices) | (Zip Code) | ||
Securities to be registered pursuant to Section 12(b) of the Act: | |||
Title of Each Class to be so Registered | Name of Each Exchange on Which Each Class is to be Registered | ||
Units, each consisting of two shares of Common Stock and a Warrant | NYSE Amex LLC | ||
Common Stock, $0.001 par value per share | NYSE Amex LLC | ||
Warrants included in the Units | NYSE Amex LLC | ||
Securities Act registration statement file number to which this form relates: | 333-163380 | ||
Securities to be registered pursuant to Section 12(g) of the Act: | |||
Not Applicable | |||
(Title of Class) | |||
Item 1. | Description of Registrant’s Securities to be Registered. |
The description of the Units, Common Stock and Warrants of CorMedix Inc. (the “Company”) set forth under the caption “Description of Capital Stock” in the Company’s Registration Statement on Form S-1 (File No. 333-163380), originally filed with the Securities and Exchange Commission on November 25, 2009, as subsequently amended (the “Registration Statement”), and in the prospectus included in the Registration Statement, is hereby incorporated by reference herein.
Item 2. | Exhibits. |
The following exhibits are filed herewith or are incorporated by reference as indicated below.
Exhibit No. | Description |
3.1 | Amended and Restated Certificate of Incorporation. (1) |
3.2 | By-laws. (1) |
3.3 | Form of Amended and Restated Certificate of Incorporation, to be effective upon the completion of the offering. (2) |
3.4 | Form of Amended and Restated By-laws, to be effective upon the completion of the offering. (2) |
3.5 | Certificate of Amendment to Amended and Restated Certificate of Incorporation. (3) |
4.1 | Specimen common stock certificate. (3) |
4.2 | Specimen Unit certificate. (3) |
4.3 | Specimen warrant certificate. (3) |
4.4 | Form of warrant agreement. (3) |
(1) | Incorporated by reference to the identically numbered exhibit to the Registration Statement on Form S-1 of CorMedix Inc. filed by CorMedix Inc. on November 25, 2009 (File No. 333-163380). |
(2) | Incorporated by reference to the identically numbered exhibit to Amendment No. 3 to the Registration Statement on Form S-1 of CorMedix Inc. filed by CorMedix Inc. on March 1, 2010 (File No. 333-163380). |
(3) | Incorporated by reference to the identically numbered exhibit to Amendment No. 4 to the Registration Statement on Form S-1 of CorMedix Inc. filed by CorMedix Inc. on March 19, 2010 (File No. 333-163380). |
-2-
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Dated: March 19, 2010 | CORMEDIX INC. | |||
By: | /s/ John C. Houghton | |||
Name: | John C. Houghton | |||
Title: | President and Chief Executive Officer |
-3-